Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-29

Clinical Trial Update: Intermittent vs Daily Tamsulosin for LUTS/BPH [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intermittent versus daily tamsulosin for lower urinary tract symptoms due to prostate obstruction; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Mansoura University | Conditions: Lower Urinary Tract Symptoms, Prostate Obstruction | Phase 4 | Status: NOT_YET_RECRUITING